Sixteen new START.nano companies are developing hard-tech solutions with the support of MIT.nano
Startup accelerator program grows to over 30 companies, almost half of them with MIT pedigrees.
Startup accelerator program grows to over 30 companies, almost half of them with MIT pedigrees.
From early motion-sensing platforms to environmental monitoring, the professor and head of the Program in Media Arts and Sciences has turned decades of cross-disciplinary research into real-world impact.
By providing holistic information on a cell, an AI-driven method could help scientists better understand disease mechanisms and plan experiments.
Co-founded by an MIT alumnus, Watershed Bio offers researchers who aren’t software engineers a way to run large-scale analyses to accelerate biology.
By enabling rapid annotation of areas of interest in medical images, the tool can help scientists study new treatments or map disease progression.
Tools build on years of research at Lincoln Laboratory to develop a rapid brain health screening capability and may also be applicable to civilian settings such as sporting events and medical offices.
A new approach for testing multiple treatment combinations at once could help scientists develop drugs for cancer or genetic disorders.
Launched with a gift from the Biswas Family Foundation, the Biswas Postdoctoral Fellowship Program will support postdocs in health and life sciences.
Researchers find nonclinical information in patient messages — like typos, extra white space, and colorful language — reduces the accuracy of an AI model.
Trained with a joint understanding of protein and cell behavior, the model could help with diagnosing disease and developing new drugs.